Yes, Oosight Spindle View is completely safe. It uses polarized light-based imaging without any physical contact with or chemical exposure to the egg, making it one of the safest tools available for non-invasive egg quality assessment. The technology does not damage the egg or compromise its viability, developmental potential, or fertilization capacity in any way. It is performed as a standard part of the pre-ICSI laboratory workflow without adding any risk to the treatment process.

No, Oosight Spindle View is not required for all IVF patients. It is recommended in selected cases where enhanced egg assessment is expected to add the most meaningful clinical value, such as advanced maternal age, poor egg quality, repeated IVF failures, or unexplained fertilization failure. Your specialist at Galwa Care Hospital will assess your individual clinical profile and advise whether Oosight imaging is the right addition to your specific IVF protocol.

Oosight imaging is performed after egg retrieval and before fertilization, as part of the ICSI preparation process. The imaging reveals the exact position of the meiotic spindle within the egg, allowing the embryologist to inject the sperm in a direction that avoids disrupting this critical structure during the microinjection. This precision reduces the risk of chromosomal errors during fertilization and supports the development of higher-quality embryos in the subsequent culture phase.

Oosight Spindle View assesses the structural readiness and maturity of the egg but does not perform full genetic screening. For chromosomal genetic testing of embryos, Preimplantation Genetic Testing (PGT-A) is the appropriate and recommended technique. Oosight enhances the precision of egg selection and the accuracy of ICSI, improving the quality of the fertilization process, but does not guarantee pregnancy. Success depends on multiple factors including embryo quality, uterine receptivity, and the overall individualized treatment protocol.